dc.contributor.author | Schelter, Bjoern O. | |
dc.contributor.author | Shiells, Helen | |
dc.contributor.author | Baddeley, Thomas C. | |
dc.contributor.author | Rubino, Christopher M. | |
dc.contributor.author | Ganesan, Harish | |
dc.contributor.author | Hammel, Jeffrey | |
dc.contributor.author | Vuksanovic, Vesna | |
dc.contributor.author | Staff, Roger T. | |
dc.contributor.author | Murray, Alison D. | |
dc.contributor.author | Bracoud, Luc | |
dc.contributor.author | Riedel, Gernot | |
dc.contributor.author | Gauthier, Serge | |
dc.contributor.author | Jia, Jianping | |
dc.contributor.author | Bentham, Peter | |
dc.contributor.author | Kook, Karin | |
dc.contributor.author | Storey, John M. D. | |
dc.contributor.author | Harrington, Charles R. | |
dc.contributor.author | Wischik, Claude M. | |
dc.date.accessioned | 2019-12-02T15:00:02Z | |
dc.date.available | 2019-12-02T15:00:02Z | |
dc.date.issued | 2019-11-26 | |
dc.identifier | 147850840 | |
dc.identifier | a775ea10-3075-4706-8691-4c38907acdbe | |
dc.identifier | 31658058 | |
dc.identifier | 85075885164 | |
dc.identifier.citation | Schelter , B O , Shiells , H , Baddeley , T C , Rubino , C M , Ganesan , H , Hammel , J , Vuksanovic , V , Staff , R T , Murray , A D , Bracoud , L , Riedel , G , Gauthier , S , Jia , J , Bentham , P , Kook , K , Storey , J M D , Harrington , C R & Wischik , C M 2019 , ' Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer’s Disease ' , Journal of Alzheimer's Disease , vol. 72 , no. 3 , pp. 931-946 . https://doi.org/10.3233/JAD-190772 | en |
dc.identifier.issn | 1387-2877 | |
dc.identifier.other | ORCID: /0000-0002-5261-5467/work/73579158 | |
dc.identifier.other | ORCID: /0000-0003-4915-4847/work/76976621 | |
dc.identifier.uri | https://hdl.handle.net/2164/13339 | |
dc.description | ACKNOWLEDGMENTS We gratefully acknowledge study investigators and the generosity of study participants. We gratefully acknowledge Professor Gordon Wilcock for critical review and commentary on drafts of the manuscript. Author’s disclosures available online (https://www.j-alz.com/manuscript-disclosures/19-0772r1). SUPPLEMENTARY MATERIAL The supplementary material is available in the electronic version of this article: http://dx.doi.org/10.3233/JAD-190772. Availability of data and materials The datasets and analyses used during the current study are available from the corresponding author on reasonable request. | en |
dc.format.extent | 16 | |
dc.format.extent | 762527 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Alzheimer's Disease | en |
dc.subject | Acetylcholinesterase inhibitor | en |
dc.subject | Alzheimer’s disease | en |
dc.subject | clinical trials | en |
dc.subject | drug interaction | en |
dc.subject | leucomethylthioninium | en |
dc.subject | population pharmacokinetics | en |
dc.subject | hydromethylthionine | en |
dc.subject | R Medicine (General) | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R1 | en |
dc.title | Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer’s Disease | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Physics | en |
dc.contributor.institution | University of Aberdeen.Institute for Complex Systems and Mathematical Biology (ICSMB) | en |
dc.contributor.institution | University of Aberdeen.Chemistry | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Grampian Data Safe Haven (DaSH) | en |
dc.contributor.institution | University of Aberdeen.Aberdeen Biomedical Imaging Centre | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.3233/JAD-190772 | |